NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 231)
Posted On: 06/01/2022 4:21:22 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences markets and other industries. The company was featured in a recent episode of The Stock Day Podcast, where its CEO Richard T. Schumacher joined Stock Day host Sever Copley to discuss PBI’s Ultra Shear Technology(TM)(“UST(TM)”) for the processing of nanoemulsions. The company has seven issued UST patents to date, including two in the U.S., with many more expected to follow. “The oil in these emulsions typically contains the valuable active ingredients, which could be a pharmaceutical or a nutraceutical, a functional cosmetic ingredient, or important food and beverage nutrients. And in UST-produced nanoemulsions with extremely tiny and controlled droplet sizes, these components suddenly become nearly 100% bioavailable, allowing the body to absorb them much more efficiently, while the solution also becomes visibly transparent – offering heightened smell, taste and texture benefits. An additional benefit is that the intense shear forces of UST also shred many microbial contents, providing enormously extended room temperature and cold-chain shelf life and stability for foods, beverages and many other products,” Schumacher said in the interview. “We plan to support four or five companies in the Early Access Program… We intend on contracting with these companies in the upcoming weeks and months and expect to get several more products onto the market with UST benefits incorporated by the end of 2022… We are confident that UST will powerfully differentiate these companies’ products into leadership roles in their respective markets. Flowing from this, our lease and license model for UST commercialization is expected to launch the revenue streams for PBI onto a dramatic new trajectory by early to mid-2023.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences markets and other industries. The company was featured in a recent episode of The Stock Day Podcast, where its CEO Richard T. Schumacher joined Stock Day host Sever Copley to discuss PBI’s Ultra Shear Technology(TM)(“UST(TM)”) for the processing of nanoemulsions. The company has seven issued UST patents to date, including two in the U.S., with many more expected to follow. “The oil in these emulsions typically contains the valuable active ingredients, which could be a pharmaceutical or a nutraceutical, a functional cosmetic ingredient, or important food and beverage nutrients. And in UST-produced nanoemulsions with extremely tiny and controlled droplet sizes, these components suddenly become nearly 100% bioavailable, allowing the body to absorb them much more efficiently, while the solution also becomes visibly transparent – offering heightened smell, taste and texture benefits. An additional benefit is that the intense shear forces of UST also shred many microbial contents, providing enormously extended room temperature and cold-chain shelf life and stability for foods, beverages and many other products,” Schumacher said in the interview. “We plan to support four or five companies in the Early Access Program… We intend on contracting with these companies in the upcoming weeks and months and expect to get several more products onto the market with UST benefits incorporated by the end of 2022… We are confident that UST will powerfully differentiate these companies’ products into leadership roles in their respective markets. Flowing from this, our lease and license model for UST commercialization is expected to launch the revenue streams for PBI onto a dramatic new trajectory by early to mid-2023.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)